ekonominyheter

TranslateRSSMobil
Why ImmunoGen, Inc. Stock Plunged 13% in October

Why ImmunoGen, Inc. Stock Plunged 13% in October

Fool.com 4/11 12:46

ImmunoGen is among biotech's worst stocks in October after the company reports weaker-than-expected third quarter results. Find out if a rebound is in the cards.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status